CPGJ, 3SBio deal

3SBio acquired a majority stake in biosimilar company Shanghai CP Guojian. 3SBio paid RMB1.4 billion ($219.1 million) to raise its stake to 54%. 3SBio had acquired a 7% stake in CP Guojian last year, according to a regulatory filing. ...